Elevance Health (ELV) Debt to Equity (2016 - 2025)
Elevance Health (ELV) has disclosed Debt to Equity for 17 consecutive years, with $0.72 as the latest value for Q3 2025.
- On a quarterly basis, Debt to Equity rose 26.86% to $0.72 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.72, a 26.86% increase, with the full-year FY2024 number at $0.72, up 20.21% from a year prior.
- Debt to Equity was $0.72 for Q3 2025 at Elevance Health, up from $0.68 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.72 in Q3 2025 to a low of $0.56 in Q1 2022.
- A 5-year average of $0.64 and a median of $0.63 in 2021 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: decreased 18.39% in 2022, then grew 26.86% in 2025.
- Elevance Health's Debt to Equity stood at $0.63 in 2021, then dropped by 1.14% to $0.62 in 2022, then decreased by 4.31% to $0.6 in 2023, then increased by 20.21% to $0.72 in 2024, then increased by 1.13% to $0.72 in 2025.
- Per Business Quant, the three most recent readings for ELV's Debt to Equity are $0.72 (Q3 2025), $0.68 (Q2 2025), and $0.7 (Q1 2025).